Durvalumab vs Liraglutide

## Durvalumab vs Liraglutide: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Liraglutide**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Liraglutide**: GLP-1 receptor agonist enhancing insulin secretion.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Liraglutide — 13 hours.

## Chemical Properties

**Type**: Durvalumab — Antibody; Liraglutide — Protein.